[1] |
Lozano CS, Ranjan M, Boutet A, et al. Imaging alone versus microelectrode recording-guided targeting of the STN in patients with Parkinson’s disease[J]. J Neurosurg, 2018: 1-6.
|
[2] |
Blasberg F, Wojtecki L, Elben S, et al. Comparison of awake vs. Asleep surgery for subthalamic deep brain stimulation in Parkinson’s disease[J]. Neuromodulation, 2018, 21(6): 541-547.
|
[3] |
Chen K, Yang YJ, Liu FT, et al. Evaluation of PDQ-8 and its relationship with PDQ-39 in China: a three-year longitudinal study[J]. Health Qual Life Outcomes, 2017, 15(1): 170.
|
[4] |
Foltynie T, Zrinzo L, Martinez-Torres I, et al. MRI-guided STN DBS in Parkinson’s disease without microelectrode recording: efficacy and safety[J]. J Neurol Neurosurg Psychiatry, 2011, 82(4): 358-363.
|
[5] |
Wang J, Ponce FA, Tao J, et al. Comparison of awake and asleep deep brain stimulation for Parkinson’s disease: a detailed analysis through literature review[J]. Neuromodulation, 2020, 23(4): 444-450.
|
[6] |
Brodsky MA, Anderson S, Murchison C, et al. Clinical outcomes of asleep vs awake deep brain stimulation for parkinson disease[J]. Neurology, 2017, 89(19): 1944-1950.
|
[7] |
Lefranc M, Derrey S, Merle P, et al. High-resolution 3-dimensional T2*-weighted angiography (HR 3-D SWAN): an optimized 3-T magnetic resonance imaging sequence for targeting the subthalamic nucleus[J]. Neurosurgery, 2014, 74(6): 615-626; discussion 627.
|
[8] |
McEvoy J, Ughratdar I, Schwarz S, et al. Electrophysiological validation of STN-SNr boundary depicted by susceptibility-weighted MRI[J]. Acta Neurochir (Wien), 2015, 157(12): 2129-2134.
|
[9] |
Alkemade A, de Hollander G, Keuken MC, et al. Comparison of T2*-weighted and QSM contrasts in Parkinson’s disease to visualize the STN with MRI[J]. PLoS One, 2017, 12(4): e0176130.
|
[10] |
Chandran AS, Bynevelt M, Lind CR. Magnetic resonance imaging of the subthalamic nucleus for deep brain stimulation[J]. J Neurosurg, 2016, 124(1): 96-105.
|
[11] |
Dimov AV, Gupta A, Kopell BH, et al. High-resolution QSM for functional and structural depiction of subthalamic nuclei in DBS presurgical mapping[J]. J Neurosurg, 2018, 131(2): 360-367.
|
[12] |
Avecillas-Chasin JM, Alonso-Frech F, Nombela C, et al. Stimulation of the tractography-defined subthalamic nucleus regions correlates with clinical outcomes[J]. Neurosurgery, 2019, 85(2): E294-E303.
|
[13] |
VanSickle D, Volk V, Freeman P, et al. Electrode placement accuracy in robot-assisted asleep deep brain stimulation[J]. Ann Biomed Eng, 2019, 47(5): 1212-1222.
|
[14] |
Blume J, Schlaier J, Rothenfuβer E, et al. Intraoperative clinical testing overestimates the therapeutic window of the permanent dbs electrode in the subthalamic nucleus[J]. Acta Neurochir (Wien), 2017, 159(9): 1721-1726.
|
[15] |
尹子霄,卢国辉,罗云云,等.全麻对帕金森病丘脑底核脑深部电刺激术术中电生理及术后疗效的影响[J].中华神经医学杂志, 2018, 17(7): 685-691.
|
[16] |
Chen T, Mirzadeh Z, Chapple KM, et al. Clinical outcomes following awake and asleep deep brain stimulation for parkinson disease[J]. J Neurosurg, 2018, 130(1): 109-120.
|
[17] |
Ostrem JL, Ziman N, Galifianakis NB, et al. Clinical outcomes using Clearpoint interventional MRI for deep brain stimulation lead placement in Parkinson’s disease[J]. J Neurosurg, 2016, 124(4): 908-916.
|
[18] |
Kochanski RB, Sani S. Awake versus asleep deep brain stimulation surgery: technical considerations and critical review of the literature[J]. Brain Sci, 2018, 8(1): 17.
|
[19] |
中国神经科学学会神经损伤与修复分会,卫健委脑卒中防治工程委员会专家委员会.移动CT床旁头部检查技术专家共识2019[J].中华神经创伤外科电子杂志, 2019, 5(2): 68-72.
|
[20] |
Venkatraghavan L, Sheshadri V. PRO: general anesthesia for deep brain stimulator insertion in patients with Parkinson disease[J]. J Neurosurg Anesthesiol, 2017, 29(3): 348-349.
|
[21] |
Ko AL, Magown P, Ozpinar A, et al. Asleep deep brain stimulation reduces incidence of intracranial air during electrode implantation[J]. Stereotact Funct Neurosurg, 2018, 96(2): 83-90.
|